The increase in net loss is due primarily to increased goodwill and intangible asset impairment charges for the impairment of goodwill related to the pharmacy services segment, a decrease in adjusted EBITDA, higher restructuring charges, higher interest expense and increased facility exit and impairment charges. These items were partially offset by a gain on the repurchase of certain bonds at a discount and a gain on sale of assets resulting from sale leasebacks and script file sales from store closures, Rite Aid said. [Read more: Rite Aid expands partnership with Afterpay ] Rite Aid's retail pharmacy segment revenues increased 8.2% over the prior year quarter driven by an extra week in the fourth quarter and an increase in both acute and maintenance prescriptions. The increase was partially offset by a reduction in COVID vaccine and testing revenue as well as store closures, the company noted.